Certain Balance Sheet Components

12 Months Ended

Mar. 31, 2022

Other Liabilities Disclosure [Abstract]

Certain Balance Sheet Components

Certain Balance Sheet Components

Inventories

Inventories consisted of the following (in thousands):

	March 31,
	2022		2021
Raw materials	$	663	$	1,390
Work in process	3,737		773
Finished goods	3,184		448
Total inventories	$	7,584	$	2,611

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31,
	2022		2021
Accrued compensation-related expenses	$	26,389	$	20,571
Accrued sales discounts, rebates, and allowances	19,390		1,315
Accrued R&D expenses	6,955		8,544
Accrued commercial expenses	7,196		7,770
Accrued other expenses	4,029		5,014
Accrued royalties payable to Takeda	2,470		301
Accrued professional fees	1,340		935
Deferred product revenue	825		162
Total accrued expenses and other current liabilities	$	68,594	$	44,612